文献速递肿瘤 PET/CT

68Ga-PSMA PET/CT 识别前列腺癌筛状结构的诊断效能

Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-04-25

本研究回顾性纳入49例术前接受mpMRI和68Ga-PSMA PET/CT、根治标本Gleason 4且无5的前列腺癌患者,共62个病灶。筛状阳性组SUVmax显著高于阴性组(每患者中位18.3 vs 9.4,每病灶18.2 vs 7.2),ADCmean和ADC10%无显著差异。SUVmax是筛状结构的显著预测因子,68Ga-PSMA PET/CT可有效识别侵袭性筛状形态。

要点

  • 筛状阳性前列腺癌SUVmax显著高于阴性(每病灶中位18.2 vs 7.2)。
  • SUVmax识别筛状结构每患者敏感度76%、特异度86%,每病灶77%、88%。
  • ADCmean和ADC10%在筛状阳性与阴性组间无显著差异。

核心结论

  • 68Ga-PSMA PET/CT可有效识别前列腺癌侵袭性筛状形态。
  • SUVmax是筛状形态的显著预测因子。

研究设计与样本

  • 回顾性纳入49例前列腺癌患者,根治标本Gleason 4且无5,术前均行mpMRI和68Ga-PSMA PET/CT。
  • 共识别62个Gleason 4病灶,按筛状状态分层,勾画匹配的mpMRI和PET感兴趣区。

主要发现

  • 62个病灶中37个(59.7%)来自34例患者(69.4%)显示筛状形态。
  • 筛状阳性与阴性组ADCmean和ADC10%相似(P>0.05)。
  • SUVmax在两组间显著不同:每患者中位18.3 vs 9.4(P=0.003),每病灶18.2 vs 7.2(P<0.001)。
  • PSMA在筛状阳性前列腺癌中显著过表达(P=0.003)。
  • SUVmax预测筛状形态的每患者OR 8.61(95%CI 4.96-25.27),每病灶OR 11.93(95%CI 6.49-33.74),均P<0.001。

关键数值与推荐

  • SUVmax识别筛状结构每患者分析敏感度76%、特异度86%。
  • SUVmax识别筛状结构每病灶分析敏感度77%、特异度88%。

临床怎么用

  • 对Gleason 4且无5的前列腺癌患者,可利用68Ga-PSMA PET/CT的SUVmax辅助识别筛状形态。
  • SUVmax较高的病灶提示筛状形态可能,有助于评估侵袭性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the diagnostic performance of 68Ga-PSMA PET/CT for identification of pathological cribriform morphology in prostate cancer (PCa). METHODS: The study retrospectively enrolled 49 PCa patients who had undergone preoperative multiparametric MRI (mpMRI) and 68Ga-PSMA PET/CT, and who had Gleason pattern (GP) 4 and absence of GP 5 on radical prostatectomy specimens. Lesions with GP 4 were outlined and stratified according to their cribriform status. Volumes of interest were drawn on matched mpMRI and PET images, and parameters including average apparent diffusion coefficient (ADCmean), tenth percentile ADC (ADC10%) and maximum standardized uptake value (SUVmax) were derived. The Mann-Whitney U test was used for continuous variables and the chi-squared test for categorical variables. Receiver operating characteristic analysis was used to compare imaging parameters in identifying cribriform morphology. The associations between cribriform-positive PCa and imaging variables were evaluated in a univariate analysis using a logistic regression model. RESULTS: A total of 62 lesions were identified in 49 patients with GP 4. Of these lesions, 37 (59.7%) in 34 patients (69.4%) showed cribriform morphology. ADCmean and ADC10% were similar between cribriform-positive and non-cribriform groups (P > 0.05), while SUVmax was significantly different (median SUVmax 18.3 vs. 9.4 per patient, P = 0.003, 18.2 vs. 7.2 per lesion, P < 0.001), yielding sensitivities and specificities of 76% and 86% in a per-patient analysis, and 77% and 88% in a per-lesion analysis, respectively. Further, PSMA was significantly overexpressed in cribriform-positive PCa (P = 0.003). SUVmax was a significant predictor of cribriform morphology in PCa (odds ratio 8.61, 95% confidence interval 4.96-25.27, per patient; odds ratio 11.93, 95% confidence interval 6.49-33.74, per lesion; both P < 0.001). CONCLUSION: 68Ga-PSMA PET/CT effectively identifies the aggressive cribriform morphology in PCa.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Gao J, Zhang C, Zhang Q, et al. Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections. Eur J Nucl Med Mol Imaging. 2019. PMID: 31025048. doi:10.1007/s00259-019-04320-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。